Despite rising opioid overdose rates among Black patients, systemic barriers and unequal access to treatment continue to hinder recovery efforts and worsen outcomes.
New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
Among 26,958 trauma patients without prior psychiatric diagnoses, 11.3% developed a new mental health condition, which was associated with elevated risks of readmission, suicide, and all-cause mortality.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.